Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 80

1.

Antiangiogenic strategies in pancreatic cancer.

Riess H.

Recent Results Cancer Res. 2008;177:123-9. Review.

PMID:
18084954
[PubMed - indexed for MEDLINE]
2.

Anti-angiogenesis therapy in pancreatic carcinoma.

Saif MW.

JOP. 2006 Mar 9;7(2):163-73. Review.

PMID:
16525200
[PubMed - indexed for MEDLINE]
Free Article
3.

Molecular-targeted agents in pancreatic cancer.

Saad ED, Hoff PM.

Cancer Control. 2004 Jan-Feb;11(1):32-8. Review.

PMID:
14749621
[PubMed - indexed for MEDLINE]
Free Article
4.

Antiangiogenic therapy in malignant glioma: promise and challenge.

Sathornsumetee S, Rich JN.

Curr Pharm Des. 2007;13(35):3545-58. Review.

PMID:
18220791
[PubMed - indexed for MEDLINE]
5.

Clinical trials of VEGF receptor tyrosine kinase inhibitors in pancreatic cancer.

Cabebe E, Fisher GA.

Expert Opin Investig Drugs. 2007 Apr;16(4):467-76. Review.

PMID:
17371195
[PubMed - indexed for MEDLINE]
6.

Antiangiogenic strategies for treatment of malignant gliomas.

Chi AS, Norden AD, Wen PY.

Neurotherapeutics. 2009 Jul;6(3):513-26. doi: 10.1016/j.nurt.2009.04.010. Review.

PMID:
19560741
[PubMed - indexed for MEDLINE]
7.

Angiogenesis and antiangiogenic strategies in pancreatic cancer.

Fisher WE, Berger DH.

Int J Gastrointest Cancer. 2003;33(1):79-88. Review.

PMID:
12909740
[PubMed - indexed for MEDLINE]
8.

Antiangiogenic therapy in malignant gliomas.

Norden AD, Drappatz J, Wen PY.

Curr Opin Oncol. 2008 Nov;20(6):652-61. doi: 10.1097/CCO.0b013e32831186ba. Review.

PMID:
18841047
[PubMed - indexed for MEDLINE]
9.

[The importance of angiogenesis in pancreatic cancer].

Myśliwiec P, Dadan J.

Przegl Lek. 2009;66(3):155-8. Review. Polish.

PMID:
19689042
[PubMed - indexed for MEDLINE]
10.

Anti-angiogenic agents in pancreatic cancer: a review.

Assifi MM, Hines OJ.

Anticancer Agents Med Chem. 2011 Jun;11(5):464-9. Review.

PMID:
21521158
[PubMed - indexed for MEDLINE]
11.

Combined targeting of EGFR-dependent and VEGF-dependent pathways: rationale, preclinical studies and clinical applications.

Tortora G, Ciardiello F, Gasparini G.

Nat Clin Pract Oncol. 2008 Sep;5(9):521-30. doi: 10.1038/ncponc1161. Epub 2008 Jul 1. Review.

PMID:
18594498
[PubMed - indexed for MEDLINE]
12.

Molecular and cellular regulators of cancer angiogenesis.

Goh PP, Sze DM, Roufogalis BD.

Curr Cancer Drug Targets. 2007 Dec;7(8):743-58. Review.

PMID:
18220534
[PubMed - indexed for MEDLINE]
13.

Combining antiangiogenic agents with metronomic chemotherapy enhances efficacy against late-stage pancreatic islet carcinomas in mice.

Bergers G, Hanahan D.

Cold Spring Harb Symp Quant Biol. 2002;67:293-300. No abstract available.

PMID:
12858552
[PubMed - indexed for MEDLINE]
14.

Drug development in pancreatic cancer: finally, biology begets therapy.

Cohen SJ, Meropol NJ.

Int J Gastrointest Cancer. 2002;32(2-3):91-106. Review.

PMID:
12794245
[PubMed - indexed for MEDLINE]
15.

Interferon-alpha in combination with chemotherapy has potent antiangiogenic properties in an orthotopic mouse model for pancreatic adenocarcinoma.

Zhu Y, Tibensky I, Schmidt J, Hackert T, Ryschich E, Jäger D, Büchler MW, Märten A.

J Immunother. 2008 Jan;31(1):28-33.

PMID:
18157009
[PubMed - indexed for MEDLINE]
16.

The matrix metalloproteinases and their inhibitors in the treatment of pancreatic cancer.

Jones L, Ghaneh P, Humphreys M, Neoptolemos JP.

Ann N Y Acad Sci. 1999 Jun 30;880:288-307. Review.

PMID:
10415874
[PubMed - indexed for MEDLINE]
17.

Antiangiogenic therapy and surgical practice.

John AR, Bramhall SR, Eggo MC.

Br J Surg. 2008 Mar;95(3):281-93. doi: 10.1002/bjs.6108. Review.

PMID:
18278790
[PubMed - indexed for MEDLINE]
18.

Targeted agents in the treatment of pancreatic cancer: history and lessons learned.

Bendell J, Goldberg RM.

Curr Opin Oncol. 2007 Jul;19(4):390-5. Review.

PMID:
17545806
[PubMed - indexed for MEDLINE]
19.

Targeting angiogenesis in head and neck cancer.

Seiwert TY, Cohen EE.

Semin Oncol. 2008 Jun;35(3):274-85. doi: 10.1053/j.seminoncol.2008.03.005. Review.

PMID:
18544442
[PubMed - indexed for MEDLINE]
20.

Challenges of antiangiogenic cancer therapy: trials and errors, and renewed hope.

Medina MA, Muñoz-Chápuli R, Quesada AR.

J Cell Mol Med. 2007 May-Jun;11(3):374-82. Review.

PMID:
17635633
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk